HUP0204555A3 - Pharmaceutical composition - Google Patents

Pharmaceutical composition

Info

Publication number
HUP0204555A3
HUP0204555A3 HU0204555A HUP0204555A HUP0204555A3 HU P0204555 A3 HUP0204555 A3 HU P0204555A3 HU 0204555 A HU0204555 A HU 0204555A HU P0204555 A HUP0204555 A HU P0204555A HU P0204555 A3 HUP0204555 A3 HU P0204555A3
Authority
HU
Hungary
Prior art keywords
pharmaceutical composition
pharmaceutical
composition
Prior art date
Application number
HU0204555A
Other languages
English (en)
Original Assignee
Bentley Pharmaceuticals Inc No
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bentley Pharmaceuticals Inc No filed Critical Bentley Pharmaceuticals Inc No
Publication of HUP0204555A2 publication Critical patent/HUP0204555A2/hu
Publication of HUP0204555A3 publication Critical patent/HUP0204555A3/hu

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4174—Arylalkylimidazoles, e.g. oxymetazolin, naphazoline, miconazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7015—Drug-containing film-forming compositions, e.g. spray-on
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
HU0204555A 2000-02-16 2001-02-16 Pharmaceutical composition HUP0204555A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US18292400P 2000-02-16 2000-02-16
PCT/US2001/005302 WO2001060325A1 (en) 2000-02-16 2001-02-16 Pharmaceutical composition

Publications (2)

Publication Number Publication Date
HUP0204555A2 HUP0204555A2 (en) 2003-05-28
HUP0204555A3 true HUP0204555A3 (en) 2004-06-28

Family

ID=22670647

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0204555A HUP0204555A3 (en) 2000-02-16 2001-02-16 Pharmaceutical composition

Country Status (17)

Country Link
EP (1) EP1257248B1 (hu)
JP (1) JP2005503318A (hu)
KR (2) KR20080049148A (hu)
CN (1) CN1422142A (hu)
AT (1) ATE526917T1 (hu)
AU (2) AU2001243189B2 (hu)
BR (1) BR0108438A (hu)
CA (1) CA2400178A1 (hu)
HU (1) HUP0204555A3 (hu)
MA (1) MA26883A1 (hu)
MX (1) MXPA02008072A (hu)
NO (1) NO20023866L (hu)
NZ (1) NZ520749A (hu)
PL (1) PL357111A1 (hu)
TW (1) TWI232756B (hu)
WO (1) WO2001060325A1 (hu)
ZA (1) ZA200206553B (hu)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6585963B1 (en) * 2001-02-15 2003-07-01 Watson Pharmaceuticals, Inc. Nail compositions and methods of administering same
GB0203276D0 (en) * 2002-02-12 2002-03-27 Novartis Ag Organic compounds
AU2003270273B2 (en) 2002-09-05 2009-03-19 Galderma S.A. Solution for ungual application
KR101093990B1 (ko) * 2003-03-21 2011-12-16 넥스메드 홀딩스 인코포레이티드 항진균성 네일 코트 및 사용 방법
US8907153B2 (en) 2004-06-07 2014-12-09 Nuvo Research Inc. Adhesive peel-forming formulations for dermal delivery of drugs and methods of using the same
US8741333B2 (en) 2004-06-07 2014-06-03 Nuvo Research Inc. Compositions and methods for treating dermatitis or psoriasis
US8741332B2 (en) 2004-06-07 2014-06-03 Nuvo Research Inc. Compositions and methods for dermally treating neuropathic pain
JP5010125B2 (ja) * 2005-09-02 2012-08-29 有限会社日本健康科学研究センター 水虫治療用フィルム製剤
EP1947938A4 (en) * 2005-11-02 2009-07-01 Cpex Pharmaceuticals Inc MACROCYCLIC FORMULATIONS FOR TRANSMEMBRANE DRUG DELIVERY
EP1959929A4 (en) * 2005-12-14 2012-08-15 Zars Pharma Inc COMPOSITIONS AND METHODS FOR TREATING DERMATOLOGICAL SUFFERING
JP5290582B2 (ja) 2005-12-28 2013-09-18 帝國製薬株式会社 爪用医薬組成物
EP2112923A1 (en) 2007-01-22 2009-11-04 Targacept Inc. Intranasal, buccal, and sublingual administration of metanicotine analogs
CN102395274B (zh) * 2009-02-13 2014-03-12 托派卡医药股份有限公司 抗真菌制剂
EA022569B1 (ru) * 2009-03-20 2016-01-29 Стифел Лэборетриз, Инк. Композиции моноглицеридов жирных кислот
GB201021386D0 (en) * 2010-12-16 2011-01-26 Burke Michael H A process for the manufacture of an antifungal nail lacquer
US9301920B2 (en) 2012-06-18 2016-04-05 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
ES2885523T3 (es) 2011-11-23 2021-12-14 Therapeuticsmd Inc Formulaciones y terapias de reposición hormonal de combinación naturales
US10806740B2 (en) 2012-06-18 2020-10-20 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
US20130338122A1 (en) 2012-06-18 2013-12-19 Therapeuticsmd, Inc. Transdermal hormone replacement therapies
US10806697B2 (en) 2012-12-21 2020-10-20 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US20150196640A1 (en) 2012-06-18 2015-07-16 Therapeuticsmd, Inc. Progesterone formulations having a desirable pk profile
US9180091B2 (en) 2012-12-21 2015-11-10 Therapeuticsmd, Inc. Soluble estradiol capsule for vaginal insertion
US10568891B2 (en) 2012-12-21 2020-02-25 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US11266661B2 (en) 2012-12-21 2022-03-08 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10471072B2 (en) 2012-12-21 2019-11-12 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US11246875B2 (en) 2012-12-21 2022-02-15 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10537581B2 (en) 2012-12-21 2020-01-21 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US8697753B1 (en) 2013-02-07 2014-04-15 Polichem Sa Method of treating onychomycosis
KR20170005819A (ko) 2014-05-22 2017-01-16 쎄러퓨틱스엠디, 인코퍼레이티드 천연 복합 호르몬 대체 제형 및 요법
KR101580077B1 (ko) 2015-03-28 2015-12-24 한국콜마주식회사 시크로피록스 함유 네일락카 조성물
US10328087B2 (en) 2015-07-23 2019-06-25 Therapeuticsmd, Inc. Formulations for solubilizing hormones
US10286077B2 (en) 2016-04-01 2019-05-14 Therapeuticsmd, Inc. Steroid hormone compositions in medium chain oils
JP2019513709A (ja) 2016-04-01 2019-05-30 セラピューティックスエムディー インコーポレーテッドＴｈｅｒａｐｅｕｔｉｃｓｍｄ， Ｉｎｃ． ステロイドホルモン薬学的組成物

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4299826A (en) * 1979-10-12 1981-11-10 The Procter & Gamble Company Anti-acne composition
US5023252A (en) * 1985-12-04 1991-06-11 Conrex Pharmaceutical Corporation Transdermal and trans-membrane delivery of drugs
US5731303A (en) * 1985-12-04 1998-03-24 Conrex Pharmaceutical Corporation Transdermal and trans-membrane delivery compositions
DE3720147A1 (de) * 1987-06-16 1988-12-29 Hoechst Ag Antimykotisch wirksamer nagellack sowie verfahren zu dessen herstellung
EP0503312B1 (fr) * 1991-03-13 1997-01-08 Firmenich Sa Procédé de préparation de la 15-pentadécanolide ou de mélanges riches en cette macrolide
EP0805673A1 (en) * 1994-10-20 1997-11-12 The Procter & Gamble Company Personal treatment compositions and/or cosmetic compositions containing enduring perfume
US5693828A (en) * 1996-05-09 1997-12-02 International Flavors & Fragrances Inc. Process for preparing lactones and intermediates therefor
WO1999039680A1 (en) * 1998-02-09 1999-08-12 Macrochem Corporation Antifungal nail lacquer and method using same
US6231875B1 (en) * 1998-03-31 2001-05-15 Johnson & Johnson Consumer Companies, Inc. Acidified composition for topical treatment of nail and skin conditions
US6495124B1 (en) * 2000-02-14 2002-12-17 Macrochem Corporation Antifungal nail lacquer and method using same

Also Published As

Publication number Publication date
KR20080049148A (ko) 2008-06-03
ZA200206553B (en) 2003-11-17
CA2400178A1 (en) 2001-08-23
AU4318901A (en) 2001-08-27
NO20023866L (no) 2002-10-01
MA26883A1 (fr) 2004-12-20
JP2005503318A (ja) 2005-02-03
NZ520749A (en) 2004-06-25
WO2001060325A1 (en) 2001-08-23
PL357111A1 (en) 2004-07-12
BR0108438A (pt) 2003-04-01
ATE526917T1 (de) 2011-10-15
AU2001243189B2 (en) 2005-06-09
HUP0204555A2 (en) 2003-05-28
NO20023866D0 (no) 2002-08-15
KR20030016227A (ko) 2003-02-26
TWI232756B (en) 2005-05-21
CN1422142A (zh) 2003-06-04
MXPA02008072A (es) 2004-04-05
EP1257248A4 (en) 2007-10-03
EP1257248A1 (en) 2002-11-20
EP1257248B1 (en) 2011-10-05

Similar Documents

Publication Publication Date Title
EG24357A (en) New Pharmaceutical composition
IL152659A0 (en) Pharmaceutical composition
HK1075889A1 (en) Pharmaceutical composition
GB2358583B (en) Pharmaceutical compositions
HUP0204555A3 (en) Pharmaceutical composition
HUP0300582A3 (en) Pharmaceutical compositions
AU6219601A (en) Pharmaceutical compositions
GB0009584D0 (en) Pharmaceutical compositions
AU8576801A (en) Pharmaceutical compositions
HUP0400553A3 (en) Pharmaceutical compositions
IL154238A0 (en) Pharmaceutical composition
GB0008485D0 (en) Pharmaceutical compositions
GB0009613D0 (en) Pharmaceutical compositions
GB0005382D0 (en) Pharmaceutical composition
GB0002691D0 (en) Pharmaceutical composition
GB0101094D0 (en) Pharmaceutical composition
GB0019599D0 (en) Pharmaceutical composition
GB0027375D0 (en) Pharmaceutical composition
GB0026716D0 (en) Pharmaceutical composition
GB0016684D0 (en) Pharmaceutical composition
GB0006301D0 (en) Pharmaceutical composition
GB0031288D0 (en) Pharmaceutical compositions
GB0031282D0 (en) Pharmaceutical compositions
GB0001337D0 (en) Pharmaceutical compositions
HU0700204D0 (en) Pharmaceutical compositions

Legal Events

Date Code Title Description
FD9A Lapse of provisional protection due to non-payment of fees